Targeting the Minimal Residual Disease in Acute Myeloid Leukemia: The Role of Adoptive Immunotherapy with Natural Killer Cells and Antigen-Specific Vaccination
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.